And by "Major sell off continues" you were referring to Friday's 10.45% uptick on higher than average daily volume?
How did you get to the article? I saw the headline & it wouldn't click thru from Yahoo or their website. I saw a tweet that it was an article to ding the data but still can't find the article.
Ah, see, I can help you understand here. People are stupid and they bought BioMarine because of hurricane Joaquin and they thought it would help biomarine stocks ...
Given the very different nature of how the 2 drugs work, I wonder how the two drugs would work together?
That could be a very interesting possibility.
60-minutes has a reputation to uphold?
OMG I am laughing so hard I'M CRYING !!!
You are SO funny. All this time I thought you were a hired short spammer in your Mom's basement in India. Now I realize you are a comedian (spamming short in your Mom's basement in India).
And by "sold all his shares in the $60s and $70s" you mean the automatic program selling that periodicly sells the shares without even knowing the price?
The same periodic selling that sold shares at $28.82 on 3/7/2014 before it shot to the $70s?
The same periodic selling that sold shares at $27.39 on 3/24/2014 before it shot to the $70s?
So much for that bogus short selling scare tactic.
Next up, go for the whining complaint about how th execs get stock options for cheap. Go ahead. That's the next one in the short sellers whine-bag.
No. It could be anytime in the 4th quarter. If you watch the options open interest, it indicates it could be before Oct. 16 (several message boards said Oct 4 but that is a Sunday, so maybe Monday morning). I expected it after that date, closer to Thanksgiving.
I do expect the data to be strong whenever it is released.
Caveat - I think SRPT's Eteplirsen is the strongest / best around. I think BMRN's Drisapersen is completely useless, and ineffective, not to mention causes liver toxicity. PTCT's Translarna is in between. Plenty good to get approved and useful to patients.
I own both and SRPT is the better bet as they are further along and have a stronger efficacy and safety profile. PTCT works differently, and we should get very strong P3 trial results in the next month or so (4th Q). SRPT rocketed up based on the good news from their trials. I think you will see a far greater run up in PTCT when the good news is released.
I think it will demonstrate good efficacy (though not necessarily great - but definitely good enough for approval, and for use) and very good safety profile. There are no other treatments, which is why this one is so important.
With respect to this latest news, probably 3-6 months. It can be accelerated since there are no current treatments in this case and that could expedite approval.
Sure the patent win for BMRN means many young boys will die, but who cares. As long as business wins out, that is a sacrifice we are willing to make!
It also doesn't matter that the whole thing will be overturned on appeal and the net effect will just delay dying boys from getting life saving medication. The point is everybody at BMRN knows Drisapersen doesn't work and causes liver toxicity, but who cares, as long as shareholders make MONEY!!!
please reply to this message if you believe little boys should die so you can achieve profits you couldn't get otherwise since the BMRN drug can't compete.
Given the favorable rulings in many countries around the world including the EU, the approval probability by the US FDA is extremely high. This is based on the efficacy and safety profile of Translarna, and not even considering that the FDA appears to be approving every drug submitted (see TheFool article that explains that the FDA seems to be approving all NDAs submitted, and they are filtering out all problems before NDA filing).
"must certainly be going badly"?
Not at all. The trials are apparently going well in terms of efficacy and safety, the only issue I know of that is less than optimal is the speed of adoption/approval in covering the cost. There have been no issues reported that I have seen about any adverse events or problems of any kind.
Why would you make that up?
He said that he expects the phase 3 to be successful. With regard to the current decline he said it is a market-wide downturn across the biotech space and nothing specific to PTCT at all.
There is no hope for any biotech stock anytime in the near future. This is a bad bear market so I'm going to keep what I have, but no way in hell I'm putting any more money into this crooked market.
Yeah, that is the same story I heard back in March at $70/share, that it was going to the moon. Forgive me if I'm skeptical, and unwilling to put any more money into such a crooked market. I'll keep what I have, but it has a long way to go to get back to where I bought in, and the current chart shows no letup in the nosedive it is in. So no thanks, I'm not going to put any more money into the stock market. Anywhere.